Investigation of Nonmotor Symptoms in First-Degree Relatives of Patients with Different Clinical Types of Parkinson's Disease

Overview

Journal Parkinsons Dis

Publisher Wiley

Date 2019 Feb 6

PMID 30719274

Citations 1

Authors

Jiang-Bing Liu

Jun-Ling Leng

Ying-Ge Wang

Yu Zhang

Tie-Yu Tang

Li-Hong Tao

Xin-Jiang Zhang

Chun-Feng Liu

Affiliations

Soon will be listed here.

Abstract

Background: Nonmotor symptoms (NMS) are prodromal characteristics of Parkinson's disease (PD). The first-degree relatives (FDR) of PD patients had a higher risk of PD and also had more NMS.

Objective: To delineate NMS in FDR of patients with different clinical types of PD.

Methods: A total of 98 PD probands were recruited; 256 siblings of them were enrolled in the FDR group. Various scales were used to assess NMS, including depression, anxiety, cognitive impairment, insomnia, constipation, excessive daytime sleepiness, rapid eye movement sleep behavior disorder (RBD), and restless legs syndrome (RLS). The incidences of NMS were further compared between the FDR groups of PD with different types.

Results: The FDR of early-onset PD (EOP) showed a higher incidence of moderate to severe depression (OR = 4.08; 95% CI: 1.12-14.92; =0.033), anxiety (OR = 4.22; 95% CI: 1.87-9.52; =0.001), and excessive daytime sleepiness (OR = 3.40; 95% CI: 1.00-11.48; =0.049) than the FDR of late-onset PD (LOP). It was also found that RBD (OR = 11.65; 95% CI: 3.82-35.54; < 0.001), constipation (OR = 4.94; 95% CI: 1.85-13.21; =0.001), sleep disorders (OR = 4.51; 95% CI: 1.73-11.78; =0.002), cognitive impairment (OR = 3.55; 95% CI: 1.62-7.77; =0.002), and anxiety (OR = 2.49; 95% CI: 1.32-4.71; =0.005) were more frequent in FDR of tremor-dominant PD (TDP) than in FDR of non-tremor-dominant PD (NTDP).

Conclusions: The siblings of patients with EOP and TDP have more NMS, presuming that they have a higher risk in the PD prodromal stage. Whether they have a greater possibility to progress into PD requires further investigation.

Citing Articles

White Matter Tract Alterations in Drug-Naïve Parkinson's Disease Patients With Excessive Daytime Sleepiness.

Ashraf-Ganjouei A, Kheiri G, Masoudi M, Mohajer B, Mojtahed Zadeh M, Saberi P Front Neurol. 2019; 10:378.

PMID: 31057475 PMC: 6477886. DOI: 10.3389/fneur.2019.00378.

References

Ross G, Abbott R, Petrovitch H, Morens D, Grandinetti A, Tung K . Association of coffee and caffeine intake with the risk of Parkinson disease. JAMA. 2000; 283(20):2674-9. DOI: 10.1001/jama.283.20.2674. View

Betarbet R, Sherer T, MacKenzie G, Panov A, Greenamyre J . Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat Neurosci. 2000; 3(12):1301-6. DOI: 10.1038/81834. View

Braak H, Del Tredici K, Rub U, de Vos R, Jansen Steur E, Braak E . Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging. 2002; 24(2):197-211. DOI: 10.1016/s0197-4580(02)00065-9. View

Tan E, Tan C, Fook-Chong S, Lum S, Chai A, Chung H . Dose-dependent protective effect of coffee, tea, and smoking in Parkinson's disease: a study in ethnic Chinese. J Neurol Sci. 2003; 216(1):163-7. DOI: 10.1016/j.jns.2003.07.006. View

Korchounov A, Schipper H, Preobrazhenskaya I, Kessler K, Yakhno N . Differences in age at onset and familial aggregation between clinical types of idiopathic Parkinson's disease. Mov Disord. 2004; 19(9):1059-64. DOI: 10.1002/mds.20061. View

Hughes A, Ben-Shlomo Y, Daniel S, Lees A . What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study. Neurology. 1992; 42(6):1142-6. DOI: 10.1212/wnl.42.6.1142. View

Farrer M . Genetics of Parkinson disease: paradigm shifts and future prospects. Nat Rev Genet. 2006; 7(4):306-18. DOI: 10.1038/nrg1831. View

Sundquist K, Li X, Hemminki K . Familial risks of hospitalization for Parkinson's disease in first-degree relatives: a nationwide follow-up study from Sweden. Neurogenetics. 2006; 7(4):231-7. DOI: 10.1007/s10048-006-0055-z. View

Wu Y, Chen C, Chao C, Ro L, Lyu R, Chang K . Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese. J Neurol Neurosurg Psychiatry. 2007; 78(9):977-9. PMC: 2117856. DOI: 10.1136/jnnp.2006.105940. View

10.

Rocca W, Bower J, Ahlskog J, Elbaz A, Grossardt B, McDonnell S . Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease. Arch Neurol. 2007; 64(10):1458-64. DOI: 10.1001/archneur.64.10.1458. View

11.

Arabia G, Grossardt B, Geda Y, Carlin J, Bower J, Ahlskog J . Increased risk of depressive and anxiety disorders in relatives of patients with Parkinson disease. Arch Gen Psychiatry. 2007; 64(12):1385-92. DOI: 10.1001/archpsyc.64.12.1385. View

12.

Thacker E, Ascherio A . Familial aggregation of Parkinson's disease: a meta-analysis. Mov Disord. 2008; 23(8):1174-83. DOI: 10.1002/mds.22067. View

13.

de Carvalho Aguiar P, Lessa P, Godeiro Jr C, Barsottini O, Felicio A, Borges V . Genetic and environmental findings in early-onset Parkinson's disease Brazilian patients. Mov Disord. 2008; 23(9):1228-33. DOI: 10.1002/mds.22032. View

14.

Braak H, Del Tredici K . Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurology. 2008; 70(20):1916-25. DOI: 10.1212/01.wnl.0000312279.49272.9f. View

15.

Fearnley J, Lees A . Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 1991; 114 ( Pt 5):2283-301. DOI: 10.1093/brain/114.5.2283. View

16.

Williams-Gray C, Evans J, Goris A, Foltynie T, Ban M, Robbins T . The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort. Brain. 2009; 132(Pt 11):2958-69. DOI: 10.1093/brain/awp245. View

17.

Iijima M, Kobayakawa T, Saito S, Osawa M, Tsutsumi Y, Hashimoto S . Differences in odor identification among clinical subtypes of Parkinson's disease. Eur J Neurol. 2010; 18(3):425-9. DOI: 10.1111/j.1468-1331.2010.03167.x. View

18.

Nicoletti A, Pugliese P, Nicoletti G, Arabia G, Annesi G, De Mari M . Voluptuary habits and clinical subtypes of Parkinson's disease: the FRAGAMP case-control study. Mov Disord. 2010; 25(14):2387-94. DOI: 10.1002/mds.23297. View

19.

Skeie G, Muller B, Haugarvoll K, Larsen J, Tysnes O . Differential effect of environmental risk factors on postural instability gait difficulties and tremor dominant Parkinson's disease. Mov Disord. 2010; 25(12):1847-52. DOI: 10.1002/mds.23178. View

20.

Pontone G, Palanci J, Bienvenu O, Liang K, Nestadt G, Rabins P . Familial aggregation of panic disturbances in Parkinson's disease. J Neuropsychiatry Clin Neurosci. 2012; 23(4):417-24. PMC: 3547673. DOI: 10.1176/jnp.23.4.jnp417. View